Premium
Perampanel: first‐in‐class AED for partial‐onset seizures
Author(s) -
Chaplin Steve,
Kelso Andrew
Publication year - 2013
Publication title -
prescriber
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.106
H-Index - 3
eISSN - 1931-2253
pISSN - 0959-6682
DOI - 10.1002/psb.1029
Subject(s) - perampanel , medicine , epilepsy , antagonist , adverse effect , partial epilepsy , ampa receptor , adjunctive treatment , anesthesia , partial seizures , pediatrics , psychiatry , pharmacology , receptor , glutamate receptor
Perampanel (Fycompa), an AMPA receptor antagonist, is licensed as adjunctive treatment of partial‐onset seizures. In our New products review, Steve Chaplin presents the clinical data relating to its efficacy and adverse events and Dr Andrew Kelso discusses its place in the treatment of epilepsy.